Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Bjerrum · SciRah

Researcher profile · Semantic Scholar

A. Bjerrum

Share profile

A. Bjerrum — researcher profile on SciRah

h-index: 16
Works: 62
Citations: 796

Most-cited papers

Clinical response and remission in severe asthma patients treated with biologic therapies.
S. Hansen, M. Søndergaard, A. von Bülow, A. Bjerrum +11 more
2023Chest108 citations Open access
Semantic Scholar
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults
L. Pérez de Llano, G. Scelo, T. Tran, Tham T. Le +51 more
2024American Journal of Respiratory and Critical Care Medicine93 citations Open access
Semantic Scholar
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
G. Scelo, C. Torres-Duque, J. Máspero, Trung Nghia Tran +82 more
2023Annals of Allergy, Asthma & Immunology87 citations Open access
Semantic Scholar
Objective and Structured Assessment of Lung Ultrasound Competence. A Multispecialty Delphi Consensus and Construct Validity Study
S. Skaarup, C. Laursen, A. Bjerrum, Ole Hilberg
2017Annals of the American Thoracic Society60 citations
Semantic Scholar
Effects of modelling examples in complex procedural skills training: a randomised study
A. Bjerrum, Ole Hilberg, T. van Gog, Peder Charles +1 more
2013Medical Education54 citations Open access
Semantic Scholar
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
M. Wechsler, G. Scelo, D. Larenas-Linnemann, C. Torres-Duque +82 more
2023American Journal of Respiratory and Critical Care Medicine51 citations Open access
Semantic Scholar
Dyad practice is efficient practice: a randomised bronchoscopy simulation study
A. Bjerrum, B. Eika, Peder Charles, Ole Hilberg
2014Medical Education46 citations
Semantic Scholar
Exploring definitions and predictors of response to biologics for severe asthma.
G. Scelo, T. Tran, Tham T. Le, Malin Faregås +51 more
2024Journal of Allergy and Clinical Immunology: In Practice34 citations Open access
Semantic Scholar
Impact of initiatinG bioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry.
Wen-Jia Chen, Trung Nghia Tran, M. Sadatsafavi, R. Murray +61 more
2023Journal of Allergy and Clinical Immunology: In Practice30 citations Open access
Semantic Scholar
Titration of anti-IL-5 biologics in severe asthma: an open-label randomised controlled trial (the OPTIMAL study)
M. Soendergaard, A. Bjerrum, L. Rasmussen, S. Lock-Johansson +4 more
2024European Respiratory Journal21 citations Open access
Semantic Scholar
Tobacco exposure and efficacy of biologic therapy in patients with severe asthma: A nationwide study from the Danish Severe Asthma Register.
M. Soendergaard, S. Hansen, A. Bjerrum, A. von Bülow +9 more
2023Journal of Allergy and Clinical Immunology: In Practice20 citations Open access
Semantic Scholar
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
Wen-Jia Chen, M. Sadatsafavi, Trung Nghia Tran, R. Murray +60 more
2022Journal of Asthma and Allergy20 citations Open access
Semantic Scholar
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
A. Bjerrum, T. Skjold, J. Schmid
2020Respiratory Medicine20 citations Open access
Semantic Scholar
Distributed practice. The more the merrier? A randomised bronchoscopy simulation study
A. Bjerrum, B. Eika, Peder Charles, Ole Hilberg
2016Medical Education Online20 citations Open access
Semantic Scholar
The number of successful injections associates with improved clinical effect in intralymphatic immunotherapy
S. Skaarup, O. Graumann, J. Schmid, A. Bjerrum +2 more
2020Allergy. European Journal of Allergy and Clinical Immunology18 citations Open access
Semantic Scholar
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma
M. Soendergaard, Frederikke Hjortdahl, Susanne Hansen, A. Bjerrum +11 more
2025European Respiratory Journal17 citations Open access
Semantic Scholar
Early Reduction of FeNO on Anti‐IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
M. Soendergaard, Susanne Hansen, K. Håkansson, A. von Bülow +10 more
2024Allergy. European Journal of Allergy and Clinical Immunology16 citations Open access
Semantic Scholar
Complete response to anti-IL5 biologics in a real-life setting
M. Soendergaard, S. Hansen, A. Bjerrum, O. Hilberg +10 more
2022ERJ Open Research14 citations Open access
Semantic Scholar
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
Susanne Hansen, K. Håkansson, M. Soendergaard, A. Bjerrum +12 more
2025Respiratory Medicine10 citations Open access
Semantic Scholar
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma Register
M. Soendergaard, S. Hansen, A. Bjerrum, O. Hilberg +10 more
2022ERJ Open Research10 citations Open access
Semantic Scholar
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Wenjia Chen, T. Tran, M. Sadatsafavi, R. Murray +62 more
9 citations
Semantic Scholar
Supratherapeutic Inhaled Corticosteroid Use in Patients Initiating on Biologic Therapies for Severe Asthma: A Nationwide Cohort Study
Frederikke Hjortdahl, M. Soendergaard, Susanne Hansen, A. Bjerrum +11 more
2025Lung7 citations Open access
Semantic Scholar
Tezepelumab in real-life practice: Characteristics of patients commenced and efficacy in a nationwide, Danish cohort of patients with severe asthma.
Marianne Baastrup Soendergaard, K. Håkansson, Susanne Hansen, A. Bjerrum +11 more
2025Journal of Allergy and Clinical Immunology: In Practice6 citations
Semantic Scholar
Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma
K. Håkansson, Susanne Hansen, M. Soendergaard, A. von Bülow +12 more
2025European Respiratory Journal6 citations
Semantic Scholar
Financial burden of productivity loss in severe asthma and impact of biologic therapy.
K. Håkansson, R. Ibsen, Niels Steen Krogh, M. Soendergaard +15 more
2025Pulmonology4 citations Open access
Semantic Scholar
Ultrasound‐guided intralymphatic immunotherapy: A single‐center trial of a clinical skills training programme
S. Skaarup, O. Graumann, J. Schmid, A. Bjerrum +2 more
2023Clinical and Experimental Allergy4 citations Open access
Semantic Scholar
Dyad training: effective, efficient and transferable. What are we waiting for?
A. Bjerrum, Anne Mette Morcke
2015Medical Education4 citations
Semantic Scholar
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis
K. Håkansson, R. Ibsen, Niels Steen Krogh, M. B. Søndergaard +15 more
2026BMJ Open Respiratory Research2 citations Open access
Semantic Scholar
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma
K. Håkansson, R. Ibsen, Niels SteenKrogh, Marianne BaastrupSoendergaard +15 more
2025Journal of Asthma2 citations Open access
Semantic Scholar
Patients with severe asthma reducing ICS treatment during treatment with biologicals do not have more frequent exacerbations.
T. Smidt-Hansen, Helle H Andersen, L. M. Pedersen, A. Bjerrum +3 more
2023Allergy and immunology2 citations
Semantic Scholar
The effectiveness of anti-IL5 biologics is comparable in previous-smokers and never-smokers with severe asthma
S. Hansen, C. Ulrik, O. Hilberg, A. von Bülow +9 more
2021Airway pharmacology and treatment2 citations
Semantic Scholar
Baseline characteristics of 36 mepolizumab-patients. Experiences from the clinical practice
A. Bjerrum, T. Skjold, J. Schmidt
20172 citations
Semantic Scholar
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study
Galathea Berner, M. Soendergaard, Susanne Hansen, A. Bjerrum +10 more
2025ERJ Open Research1 citations Open access
Semantic Scholar
Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
M. Soendergaard, K. Håkansson, Susanne Hansen, A. Bjerrum +11 more
2025Clinical and Experimental Allergy1 citations Open access
Semantic Scholar
Remission on biologics for severe asthma - 5 years of follow-up
A. Bjerrum, Soran Peshbahar, T. Skjold, J. Schmid
2024Airway pharmacology and treatment1 citations
Semantic Scholar
Oral glucocorticoid-sparing effects of mepolizumab. A real-life study.
A. Bjerrum, J. Schmid, T. Skjold
2018Airway pharmacology and treatment1 citations
Semantic Scholar
Assessing the impact of earlier initiation of biologics on clinical remission and other outcomes in a global real-life severe asthma cohort from CHRONICLE, ISAR and OPCRD.
G. Canonica, G. Christoff, Ming-Ju Tsai, Trung N. Tran +137 more
2026Chest0 citations Open access
Semantic Scholar
Five-year inhaled, systemic, and total corticosteroid exposure reduction during anti‒interleukin-5 receptor alpha treatment for severe asthma.
K. Håkansson, Susanne Hansen, M. Soendergaard, A. Sverrild +11 more
2026Annals of Allergy, Asthma & Immunology0 citations Open access
Semantic Scholar
Second-line dupilumab after anti-IL5/Rα failure: remission rates and clinical outcomes in severe asthma.
Susanne Hansen, Kjell Erik Julius Håkansson, M. Soendergaard, A. Sverrild +11 more
2026Journal of Allergy and Clinical Immunology: In Practice0 citations Open access
Semantic Scholar
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study
Susanne Hansen, Ming-Ju Tsai, T. Tran, John D. Blakey +136 more
2026Journal of Asthma and Allergy0 citations Open access
Semantic Scholar
Upper airway and quality of life improvements with dupilumab treatment for severe asthma in the Danish Severe Asthma Registry
Andreas Lillieroth Bricaud, J. Bruun, K. Håkansson, Susanne Hansen +15 more
2025Airway pharmacology and treatment0 citations
Semantic Scholar
Baseline biomarkers predicting remission of severe asthma after switching biologics
Susanne Hansen, K. Håkansson, M. Soendergaard, A. Bjerrum +12 more
2025Airway pharmacology and treatment0 citations
Semantic Scholar
Five years of anti-IL 5 for severe asthma: promising long-term efficacy, but sustained remission is rare
K. Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, A. von Bülow +12 more
2025Airway pharmacology and treatment0 citations
Semantic Scholar
Efficacy of Dupilumab in Patients with Severe Asthma and Co-existing COPD
Sammy Ameri, Susanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard +13 more
2025Airway pharmacology and treatment0 citations
Semantic Scholar
Impact of biologic therapy on the cumulative and running societal financial burden of severe asthma – a 19-year cost analysis
K. Håkansson, R. Ibsen, Niels Steen Krogh, Marianne Baastrup Soendergaard +15 more
2025Epidemiology0 citations
Semantic Scholar
The first 18 months of tezepelumab in real-life practice: Characteristics of patients commenced and efficacy in a nationwide, complete cohort of patients with severe asthma
Marianne Baastrup Soendergaard, K. Haakansson, Susanne Hansen, A. Bjerrum +11 more
2025Airway pharmacology and treatment0 citations
Semantic Scholar
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
Wenjia Chen, T. Tran, M. Sadatsafavi, Ruth B Murray +61 more
2024Journal of Allergy and Clinical Immunology: In Practice0 citations Open access
Semantic Scholar
Late Breaking Abstract - The impact of biologic therapy on work capacity and workforce withdrawal in severe asthma
K. Håkansson, R. Ibsen, Marianne Baastrup Soendergaard, Niels Steen Krogh +14 more
2024Epidemiology0 citations
Semantic Scholar
Cumulative corticosteroid exposure in severe asthma prior to commencing biologics – a nationwide 27-year observational study
Frederikke Hjortdahl, Susanne Hansen, M. Søndergaard, A. von Bülow +14 more
2024Epidemiology0 citations
Semantic Scholar
Reduction in FeNO on anti-IL5 biologics is associated with clinical remission of severe asthma
Marianne Baastrup Soendergaard, Susanne Hansen, K. Haakansson, A. von Bülow +6 more
2024Airway pharmacology and treatment0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. von Bülow×37
Invite
A. von Bülow — researcher profile on SciRah
C. Porsbjerg×34
Invite
C. Porsbjerg — researcher profile on SciRah
C. Ulrik×32
Invite
C. Ulrik — researcher profile on SciRah
O. Hilberg×30
Invite
O. Hilberg — researcher profile on SciRah

×23

Invite

L. Rasmussen — researcher profile on SciRah

Invite

C. Johnsen — researcher profile on SciRah

K. Håkansson×19

Invite

K. Håkansson — researcher profile on SciRah

Roxana Vijdea×17

Invite

Roxana Vijdea — researcher profile on SciRah

M. Soendergaard×16

Invite

M. Soendergaard — researcher profile on SciRah

Invite

J. Schmid — researcher profile on SciRah

S. Johansson×14

Invite

S. Johansson — researcher profile on SciRah

Invite

L. Dongo — researcher profile on SciRah